Skip to Content
MilliporeSigma

Skip To

PHR1554

Supelco

Heptane

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

Heptane

Sign Into View Organizational & Contract Pricing

Select a Size

Change View
0.44 MG
₹20,185.00

About This Item

Linear Formula:
CH3(CH2)5CH3
CAS Number:
Molecular Weight:
100.20
Beilstein:
1730763
EC Number:
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

₹20,185.00


Please contact Customer Service for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

certified reference material
pharmaceutical secondary standard

Quality Level

Agency

traceable to USP 1304209

vapor density

3.5 (vs air)

vapor pressure

40 mmHg ( 20 °C)
83 mmHg ( 37.7 °C)

CofA

current certificate can be downloaded

autoignition temp.

433 °F

expl. lim.

7 %

packaging

ampule of 3x1.2 mL each

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

refractive index

n20/D 1.387 (lit.)

bp

98 °C (lit.)

mp

−91 °C (lit.)

density

0.684 g/mL at 25 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

SMILES string

CCCCCCC

InChI

1S/C7H16/c1-3-5-7-6-4-2/h3-7H2,1-2H3

InChI key

IMNFDUFMRHMDMM-UHFFFAOYSA-N

General description

Heptane is a non-polar organic solvent and a straight-chain alkane with seven carbon atoms. It is generally employed in the synthesis of pharmaceuticals and considered to be one of the green solvents.[1][2]
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Application

Heptane may be used as a pharmaceutical reference solvent standard for the determination of the analyte in bulk drug and pharmaceutical formulations by gas chromatography.[3][4]
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAC0594 in the slot below. This is an example certificate only and may not be the lot that you receive.

Recommended products

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
RTC0000911304209HX0078
Heptane Pharmaceutical Secondary Standard; Certified Reference Material

PHR1554

Heptane

Heptane United States Pharmacopeia (USP) Reference Standard

1304209

Heptane

Heptane Meets Reagent Specifications for testing USP/NF monographs OmniSolv®

HX0078

Heptane

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

technique(s)

-

technique(s)

-

technique(s)

HPLC: suitable

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical small molecule

application(s)

pharmaceutical (small molecule)

application(s)

general analytical

format

neat

format

-

format

neat

format

-

Quality Level

300

Quality Level

300

Quality Level

-

Quality Level

100

grade

certified reference material, pharmaceutical secondary standard

grade

certified reference material, pharmaceutical secondary standard

grade

pharmaceutical primary standard

grade

HPLC grade

storage temp.

2-30°C

storage temp.

2-30°C

storage temp.

-

storage temp.

room temp


Still not finding the right product?

Explore all of our products under Heptane


Signal Word

Danger

Hazard Statements

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Central nervous system

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

24.8 °F - closed cup

Flash Point(C)

-4 °C - closed cup



  • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library


    Eberhard P Scholz et al.
    Naunyn-Schmiedeberg's archives of pharmacology, 376(4), 275-284 (2007-10-30)
    The anticholinergic antiparkinson drug orphenadrine is an antagonist at central and peripheral muscarinic receptors. Orphenadrine intake has recently been linked to QT prolongation and Torsade-de-Pointes tachycardia. So far, inhibitory effects on I (Kr) or cloned HERG channels have not been
    Pål Gjerden et al.
    British journal of clinical pharmacology, 67(2), 228-233 (2008-12-20)
    Anticholinergic antiparkinson drugs are used to ameliorate extrapyramidal symptoms caused by either Parkinson's disease or antipsychotic drugs, but their use in the treatment of Parkinson's disease is assumed to be in decline. Patients with psychotic conditions have a high prevalence
    Pål Gjerden et al.
    British journal of clinical pharmacology, 68(2), 238-242 (2009-08-22)
    Extrapyramidal side-effects induced by antipsychotic drugs are treated with dose reduction or substitution with another antipsychotic drug or by the addition of anticholinergic antiparkinson agents. The withdrawal of orphenadrine from the Norwegian market provided a possibility to investigate to what

    Customers Also Viewed